Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H Cabell

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2017
Recent developments in the science of proarrhythmic cardiac safety of new drugsJ Rick Turner, Dilip R Karnad, Christopher H Cabell, et al.
Current Infectious Disease Reports|July 22, 2004
Issues in the Management of Endocarditis Caused by Resistant Gram-positive OrganismsMartin E. Stryjewski, Vivian H. Chu, Christopher H. Cabell, et al.
Pulmonary Circulation|June 4, 2020
Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteersJohn S Grundy, Christopher D King, John W Adams, et al.
The American Journal of Cardiology|March 5, 2003
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failureBenjamin H Trichon, G Michael Felker, Linda K Shaw, et al.
American Journal of Therapeutics|January 24, 2014
Cardiovascular safety monitoring during oncology drug development and therapyJ Rick Turner, Gopi Krishna Panicker, Dilip R Karnad, et al.
Scandinavian Journal of Infectious Diseases|March 17, 2007
Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patientsOlcay Aksoy, Laura T Meyer, Christopher H Cabell, et al.
Circulation|September 13, 2003
Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitationBenjamin H Trichon, Donald D Glower, Linda K Shaw, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
The American Journal of Cardiology|May 13, 2008
Relation of troponin elevation to outcome in patients with infective endocarditisJonathan B Purcell, Mahesh Patel, Amit Khera, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2017
Recent developments in the science of proarrhythmic cardiac safety of new drugsJ Rick Turner, Dilip R Karnad, Christopher H Cabell, et al.
Current Infectious Disease Reports|July 22, 2004
Issues in the Management of Endocarditis Caused by Resistant Gram-positive OrganismsMartin E. Stryjewski, Vivian H. Chu, Christopher H. Cabell, et al.
Pulmonary Circulation|June 4, 2020
Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteersJohn S Grundy, Christopher D King, John W Adams, et al.
The American Journal of Cardiology|March 5, 2003
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failureBenjamin H Trichon, G Michael Felker, Linda K Shaw, et al.
American Journal of Therapeutics|January 24, 2014
Cardiovascular safety monitoring during oncology drug development and therapyJ Rick Turner, Gopi Krishna Panicker, Dilip R Karnad, et al.
Scandinavian Journal of Infectious Diseases|March 17, 2007
Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patientsOlcay Aksoy, Laura T Meyer, Christopher H Cabell, et al.
Circulation|September 13, 2003
Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitationBenjamin H Trichon, Donald D Glower, Linda K Shaw, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
The American Journal of Cardiology|May 13, 2008
Relation of troponin elevation to outcome in patients with infective endocarditisJonathan B Purcell, Mahesh Patel, Amit Khera, et al.
Pageof 7